For a long time, the Medicare program paid higher prices in the Part B program, but these prices subsidized new treatments (to which we also tend to get first access)
Dihexa is not FDA-approved for any indication in the United States
Yapici-Esper, H., Appadurai, V., Eren, C
The most commonly reported side effects in non-diabetic users are gastrointestinalnausea, constipation, and occasional vomitingwhich typically diminish after the first 24 weeks as the body adjusts to the medication
They do not offer compounded tirzepatide
People couldnt get enough of them (literally, causing monthslong shortages) and it seemed like the higher dose you took, the more weight youd lose and the better off youd be